In patients with IBS, we observed a decline in IL-6, IFN-γ, TNF-α, and secretory IgA levels in fecal samples and, simultaneously, an increase in IL-10 and IL-17A levels after supplementation. Here, IL6 is linked to irritable bowel syndrome.